✦ LIBER ✦

Docetaxel in ovarian cancer: Phase III perspectives and future development

✍ Scribed by Stanley B. Kaye; Paul A. Vasey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statistical methodology of phase III can

✍ R Sylvester; M Van Glabbeke; L Collette; S Suciu; B Baron; C Legrand; T Gorlia; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Gemcitabine in epithelial ovarian cancer

✍ D. LORUSSO; G. FERRANDINA; E. FRUSCELLA; L. MARINI; V. ADAMO; G. SCAMBIA 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Phase II Study of Gemcitabine and Doceta

✍ Garcia, Agustin A.; Yessaian, Anne; Pham, Huyen; Facio, Grace; Muderspach, Laila 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 177 KB

Future developments and new research in

✍ Richard B. Alexander; Donald S. Coffey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Perspectives and opportunities: docetaxe

✍ Mark R. Green 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase II and Phase III Trials: Docetaxel

📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB